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Abstract
Membrane proteins are of outstanding importance in biology, drug discovery and vaccination. A 
common limiting factor in research and applications involving membrane proteins is the ability to 
solubilize and stabilize membrane proteins. Although detergents represent the major means for 
solubilizing membrane proteins, they are often associated with protein instability and poor 
applicability in structural and biophysical studies.
Here, we present a novel lipoprotein nanoparticle system that allows for the reconstitution of 
membrane proteins into a lipid environment that is stabilized by a scaffold of Saposin proteins. We 
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showcase the applicability of the method on two purified membrane protein complexes as well as 
the direct solubilization and nanoparticle-incorporation of a viral membrane protein complex from 
the virus membrane. We also demonstrate that this lipid nanoparticle methodology facilitates high-
resolution structural studies of membrane proteins in a lipid environment by single-particle 
electron cryo-microscopy (cryo-EM) and allows for the stabilization of the HIV-envelope 
glycoprotein in a functional state.
 Introduction
Membrane proteins are encoded by approx. 30% of all open reading frames1. They are an 
important class of drug targets, as more than >60% of drugs in clinical use target this class 
of proteins2. Membrane proteins play essential roles in many cellular processes, such as 
signal transduction, cell-to-cell communication, membrane transport as well as lipid and 
energy metabolism. However, membrane proteins are difficult to study due to their 
instability and tendency to aggregate when extracted from their natural lipid bilayer 
environment. In order to maintain the integrity of membrane proteins, an artificial 
hydrophobic environment is needed. Detergent micelles are the most common approach to 
solubilize membrane proteins, but often have adverse effects on protein activity, stability and 
solubility or interfere with the experimental set-up3-5.
A major challenge is maintaining membrane proteins in a lipid-like environment while 
keeping them stable and monodisperse in solution, so that they become accessible for 
biochemical, biophysical and structural studies. Methods to reconstitute membrane proteins 
into lipid nanoparticles provide a potential solution for this challenge. Current nanoparticle 
technologies that address this problem involve liposomes and high-density lipoprotein 
(rHDL) particles6,7 based on Apolipoproteins, also termed Nanodiscs. Both approaches have 
been used routinely for biochemical and biophysical studies of membrane proteins and were 
also applied for structure determination by single particle cryo-EM8-10. However, both 
technologies are relatively laborious to optimize for individual membrane proteins.
Here, we present a novel lipid nanoparticle system that is based on the Saposin protein 
family. Saposins are known to be modulators of lipid membranes11,12, mostly at an acidic 
pH within lysosomes. Given their lipid binding properties, we hypothesized that they could 
be used to generate a Saposin-based nanoparticle system for the incorporation of membrane 
proteins (Fig. 1). In this study, we developed a methodology to reconstitute membrane 
proteins into Saposin-lipoprotein (Salipro) nanoparticles, allowing to stabilize fragile 
membrane protein complexes in detergent-free buffer systems for functional and structural 
studies such as high-resolution structure determination by single particle cryo-EM.
 Results
 Generation of Saposin-lipid nanoparticles
Members of the Saposin protein family have membrane binding and lipid transport 
properties11,12. Several crystal structures of Saposin proteins have been reported, both in the 
absence and presence of lipids or detergents13-16. It was recently demonstrated that Saposin 
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A forms lipid complexes at a lysosomal acidic pH, when incubated with unilamellar 
liposomes16.
Since Saposin proteins have the capability of forming lipid complexes, we rationalized that 
these could be used as scaffolding proteins for a lipid nanoparticle system to reconstitute 
membrane proteins into a lipid environment. Our aim was therefore to establish a more 
versatile system for incorporating membrane proteins into a lipid nanoparticle system based 
on Saposin proteins, without using liposomes and an acidic pH.
At first, we tested whether it would be possible to incorporate lipids into Saposin A 
complexes, in the absence of an acidic pH and in the absence of liposomes We incubated 
Saposin A (see Methods) with detergent-solubilised phospholipids at a physiological pH 7.4, 
followed by detergent removal via an initial dilution step and subsequent size-exclusion 
chromatography (SEC) without detergent in the buffer. We could observe a significant shift 
in the retention time of the Saposin A SEC peak after incubation with lipids such as 
phosphatidylcholine (PC), phosphatidylglycerol (PG), phosphatidylserine (PS) or brain lipid 
extract, supporting the incorporation of lipids to form soluble Saposin A based lipoprotein 
particles (Fig. 2a). In contrast, no shift was observed after incubation with POPE and an 
Escherichia coli (E. coli) total lipid extract (Supplementary Fig. 1a), indicating a certain 
degree of lipid preference for Saposin A at physiological pH11. Negative stain electron 
microscopy of Saposin-lipid complexes also revealed monodisperse particles 
(Supplementary Fig. 1b). Increasing the lipid-to-Saposin ratio leads to a slight increase in 
particle size (Supplementary Fig. 1c). In general, the gel-filtration analyses of the Saposin-
lipid complexes displayed symmetric peaks, corresponding to the formation of homogenous 
nanoparticle populations. Salipro nanoparticles remain stable after concentration using 
standard centrifugal filter units. Moreover, particles that had been concentrated and frozen 
maintained their assembled state as judged by analytical SEC when thawed and incubated 
for 10 minutes at temperatures from 0-95 °C, indicating a high degree of thermostability 
(Supplementary Fig. 1d).
 Incorporation of membrane proteins into Salipro particles
Studying integral membrane proteins in a lipid environment still represents one of the 
biggest challenges for structural biology, biochemical studies and drug development. Given 
the Salipro nanoparticles’ capacity of integrating detergent-solubilized lipids at a 
physiological pH, we focused on the potential of reconstituting membrane proteins. We 
incubated detergent purified membrane proteins with lipids and Saposin A, followed by 
detergent removal steps mentioned above. The model proteins used were an archaeal 
mechanosensitve channel17 (T2, 4 predicted transmembrane helices per monomer, 32.9 kDa, 
putative homopentamer) and a bacterial peptide transporter18,19 (POT1, 14 transmembrane 
helices per monomer, 56 kDa, homotetramer).
It should be noted that in the absence of detergent in the SEC buffer, membrane proteins are 
not soluble, but will aggregate and not elute from the column. In contrast, after incubation 
with Saposin A and lipids, the gel-filtration profile of the archaeal T2 channel displays three 
symmetric peaks (Fig. 2b), with the first peak corresponding to T2 channel incorporated into 
Salipro nanoparticles, while the second and third peak originate from lipid-only Salipro 
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nanoparticles and monomeric Saposin A, respectively. Accordingly, Saposin A, lipids and 
the T2 channel associate in such way that they form water-soluble particles with 
incorporated membrane protein.
Peak fractions corresponding to Salipro-T2 were pooled, concentrated and flash-frozen prior 
to further analysis via electron microscopy (EM). Salipro-T2 particles that had been 
concentrated, frozen, thawed and diluted maintained their assembled state as judged by 
analytical SEC (Supplementary Fig. 2a). Negative stain EM revealed a homogenous 
population of single particles that adopt various orientations on the grid (Fig. 2c, d). The 
particles look significantly more distinct than the T2 channel embedded in micelles of the 
detergent n-Dodecyl β-D-maltoside (DDM)17. In side-views, both individual particles as 
well as two dimensional (2D) class averages of Salipro-T2 particles display two moieties of 
different sizes, representing a more compact domain and a bilobed domain (Fig. 2d).
 Cryo-electron microscopy of Salipro-POT
Proton-coupled oligopeptide transporters (POTs) regulate the uptake of di- and tripeptides 
and are conserved among all kingdoms of life. We used the bacterial peptide transporter 
PeptTSo2, labeled POT, as model protein for our studies. For the integration of this POT into 
Salipro nanoparticles, we incubated the purified membrane protein with Saposin A and 
lipids. The gel-filtration profile of the bacterial peptide transporter exhibits three symmetric 
peaks (Supplementary Fig. 2b), with the first peak corresponding to the membrane protein 
incorporated into Salipro nanoparticles. Generally, the formation of Salipro particles with 
incorporated membrane proteins such as POT is feasible within a physiological pH range 
(Supplementary Fig. 2c). Prior to further analysis, peak fractions of Salipro-POT were 
pooled, concentrated and flash-frozen. Thermal unfolding analysis using dye-free 
differential scanning fluorimetry20 revealed that the peptide transporter is significantly more 
stable when embedded in Salipro nanoparticles (Tm 72°C) compared to detergent Nonyl-β-
D-Maltopyranoside (Tm 43°C) (Supplementary Fig. 2d).
We used single-particle cryo electron microscopy (cryoEM) to determine the structure of the 
bacterial peptide transporter embedded within Salipro nanoparticles. From a cryoEM 
perspective, the POT transporter is a challenging target as it is mostly composed of 
transmembrane helices and contains only short loop regions that are not embedded in the 
membrane. Thus, there are no significant features outside of the membrane to align images 
of the molecules, which make it an extremely difficult target for single-particle cryo-EM. 
Cryo-EM grids of the Salipro-POT complex were prepared by the standard plunge-freezing 
method21 at a moderate concentration (0.7 mg/ml). In contrast, for single-particle cryoEM of 
membrane proteins in detergent, usually thick ice and high protein concentrations are 
required to obtain reasonable data22. Cryo-EM images revealed that frozen hydrated 
complexes of Salipro-POT are homogenous and monodisperse (Fig. 3a).
A cryo-EM data set was collected following established data acquisition and motion 
correction procedures23. Two-dimensional (2D) class averages display the features of 
secondary and tertiary structure, as well as the tetrameric organization of the peptide 
transporter (Fig. 3b). Using a total of 9,913 particles, we determined a 3D reconstruction 
with a 4-fold symmetry to a resolution of 6.5 Å (estimated with the gold-standard FSC = 
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0.143 criterion24 (Fig. 3c). All secondary structural features are clearly resolved in the final 
3D density map (Fig. 3d). The Euler angle distribution shows that particles are evenly 
distributed in different orientations in vitreous ice (Fig. 3e). The local resolution in the core 
region of the nanoparticle, representing the transmembrane helices of the peptide transporter, 
is significantly higher than the regions that can be attributed to the more flexible Saposin-
lipid scaffold (Fig. 3f, Supplementary Fig. 3). The cryo-EM density reveals a square-shaped 
disc with an overall dimension of 12 nm × 12 nm × 5 nm with well-resolved transmembrane 
helices (Fig. 4a, Supplemental Movie). Given the size (Fig. 4a) and the apparent 
stoichiometry (Supplementary Fig. 2e) of Salipro-POT1, each particle is composed of four 
POT molecules and four Saposin A molecules (Fig. 4a, Supplemental Movie).
The crystal structure of the peptide transporter19 could be directly docked into the cryo-EM 
density as a rigid body without modification (Fig. 4). While the transmembrane helices were 
well resolved, the Salipro scaffold of Saposin and lipids appears to be more flexible (Fig. 3f, 
Supplementary Fig. 3). Fitting of Saposin A into the scaffold density was therefore done 
with a map displayed at a lower isosurface level (Fig. 4a, Supplementary Video 1). The 
general dimensions of the Salipro scaffold are in agreement with a recently published 
structure of Saposin A16. At the current low resolution for the Saposin-lipid belt, it cannot be 
excluded that Saposin might also directly interact with the transmembrane helices of the 
bacterial transporter. However, we hypothesize that if Saposin would indeed bind directly to 
a transmembrane helix, it should be less flexible and thus, in turn, be possible to also resolve 
the α-helices of Saposin. However, this is not the case, the flexibility and hence lower 
resolution of the Saposin-lipid scaffold does not allow for resolving the α-helices of Saposin 
(Fig. 3f, Supplementary Fig. 3).
The cryo-EM density allows for the clear identification and positioning of the POT 
transmembrane helices (Fig. 4b). Moreover, the EM density reveals loop and helix densities 
that could not be modeled in the crystal structure of this peptide transporter19. The map also 
exhibits bulky side-chain densities from amino acids, positions of which are in good 
agreement to the rigid body fitting of the crystal structure of the peptide transporter (Fig. 
4c).
Note that the Salipro-POT complex has almost no soluble domains exposed outside of the 
membrane. Generally, it was believed that membrane proteins ought to contain a soluble 
domain of considerable size exposed outside of the membrane to facilitate image alignment. 
While the four-fold symmetry of the tetrameric POT transporter facilitates cryo-EM 3-D 
reconstruction, it is still to our surprise that Salipro-POT complex can be reconstructed to 
subnanometer resolution from only 9,913 particles.
 Stabilization of the functional HIV-1 spike protein
The membrane proteins of enveloped viruses often represent potent antigens that can be used 
for vaccination25. The trimeric HIV-1 envelope glycoprotein (HIV-1 spike), which mediates 
the viral entry into host target cells, may serve as a prominent example, as it is the only viral 
protein exposed to the immune system by intact HIV-1 particles. The HIV-1 spike is highly 
unstable in detergent26-28 (Supplementary Fig. 4).
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Given the potential of the Saposin-based nanoparticle system to incorporate purified 
membrane proteins, we also investigated the prospect of incorporating membrane proteins 
from the original viral membrane. Here, we used the fragile HIV-1 spike as a model system 
(Fig. 5a). We established a rapid reconstitution protocol where we extracted the HIV-1 spike 
from the membrane of virus like particles (VLPs) and reconstituted the membrane protein 
into Salipro nanoparticles. To do so, we incubated VLPs containing HIV-1 spikes with 
detergent and Saposin A, followed by a fast removal of detergent-micelles using spin SEC 
columns, thereby forcing the hydrophobic moieties of the initial mixture to self-assemble 
into Salipro nanoparticles (Salipro-HIV-spikes) (Fig. 5b, Supplementary Fig. 5).
Initially six detergents with high critical micelle concentration (CMC) were screened. 
HEGA-10, MEGA-10 and C-HEGA-11 preserved the trimeric HIV-1 spike protein during 
solubilisation on ice for 10 min, as judged by BN-PAGE gel shift assay (Supplementary Fig. 
4a). It should be noted that the viral spikes in detergent dissociated completely into 
monomers within 30 min at 37°C (Supplementary Fig. 4b). In order to stabilize the trimeric 
association, we reconstituted the HIV-1 spike protein into Salipro nanoparticles. Purified 
VLPs were solubilized with 9 mM HEGA-10 in the presence of 0.1 mg/ml Saposin A (for 
optimization see Supplementary Fig. 6), followed by removal of HEGA-10 using spin SEC 
columns (Supplementary Fig. 5). BN-PAGE analysis revealed that HIV-spikes eluted as 
soluble trimers only in the presence of Saposin A, indicating reconstitution into Salipro-
HIV-spike particles (Fig. 5c). If Saposin A was omitted, HIV-spikes could not be resolved 
due to protein aggregation (Fig. 5c).
A second purification step using lectin affinity chromatography successfully removed viral 
matrix (MA) and capsid (CA) proteins as well as the excess of unbound Saposin A, leading 
to a pure Salipro-HIV-spike sample as determined by SDS-PAGE (Fig. 5d, Supplementary 
Fig. 5).
We investigated the stability and functionality of radiolabelled lectin-purified Salipro-HIV-
spikes by BN-PAGE. While detergent solubilized HIV-spikes dissociated completely within 
30 min at 37°C (Supplementary Fig. 4), Salipro-HIV-spikes remained intact for 16h and 90h 
at 37 °C as judged by BN-PAGE (Fig. 5e). Subsequent to the 16h and 90h incubation at 
37 °C, we assessed the functionality and native features of the Salipro-HIV-spikes by 
binding to several protein ligands for additional 2h at 37°C. Binding of these ligands to the 
Salipro-HIV-spike increases its apparent molecular weight and therefore reduces the 
mobility in BN-PAGE correspondingly as shown before with detergent-HIV-spike 
complexes28.
The broadly neutralizing antibody PG16 binds to the variable loops V1-V2 and V3 at the top 
of preferentially intact and functional trimeric HIV-1 spikes28-30.
We found that PG16 antibody bound efficiently to the Salipro-HIV-spikes even after 16h and 
90h incubation at 37 °C (Fig. 5e). In addition, a soluble version of the primary HIV-1 
receptor CD4 (sCD4) bound stoichiometrically to the Salipro-HIV-spikes (Fig. 5e). Binding 
of CD4 induces a conformational change in the spike, which is essential for the binding of 
the co-receptor site-directed monoclonal antibody 17b Fab31,32. In order to examine this 
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functionality, we analysed the binding of the 17b Fab to Salipro-HIV-spike-sCD4 complexes 
via BN-PAGE. The analysis revealed efficient binding of 17b Fab to the Salipro-HIV-spike-
sCD4 complex (Fig. 5e). Importantly, 17b Fab did not bind to the Salipro-HIV-1-spikes in 
the absence of sCD4 (Fig. 5e). This confirmed that sCD4 binding induced proper 
conformational changes to the reconstituted Salipro-HIV-spikes. Altogether, our data 
demonstrates that the HIV-1 spike can be properly reconstituted into Salipro nanoparticles, 
preserving the fragile trimeric HIV-1 spike structure in a native, stable and functional state 
for at least 90h at 37 °C.
 Discussion
Integral membrane proteins are difficult to study in a lipid environment. Detergents may 
keep membrane proteins in a soluble state once extracted from the membrane, however they 
are associated with a range of problems with respect to membrane protein stability and 
applicability in biophysical or structural studies3-5.
Here, we demonstrate that it is possible to incorporate membrane proteins into Saposin-
based lipid nanoparticles that allow for structural and functional studies of membrane 
proteins in detergent-free buffer systems. The formation of Salipro nanoparticles is 
comparably straightforward by mixing lipids with membrane proteins and Saposin A, which 
leads to a rapid self-assembly reconstitution process. Moreover, it is also possible to 
incorporate membrane proteins from the viral membrane by mixing Saposin A with virus 
particles, leading to a fully functional viral membrane protein embedded in Salipro 
nanoparticles.
The nanoparticles are composed of lipids and Saposin A, a member of the saposin-like 
protein family11-16. This class of proteins is composed of amphipathic helices and six 
invariable cysteine residues that form disulphide bridges, leading to an extraordinary 
stability of the domains11. In turn, we assume that the intrinsic stability of the Saposin 
proteins, which surround the lipid core of the nanoparticle, also renders the nanoscale 
protein-lipid complexes remarkably stable and uniform in a wide temperature range 
(Supplementary Fig. 1c).
Various methodologies have been developed to stabilize membrane proteins in an aqueous 
environment7,33-40 (Supplementary Table 1). To achieve high-resolution, both amphipoles 
and maltose-neopentyl glycol-3 analogs have been shown to facilitate structural studies of 
membrane proteins41,42, indicating their stabilizing effect on membrane proteins and their 
tight binding to the membrane protein. However, these systems do not provide a lipid 
environment, which is known to be of great importance for membrane protein structure and 
function.
In turn, discoidal HDL particles, also termed Nanodiscs7,43, provide a lipid environment, 
albeit do not bind tightly to the TM-helices of the membrane protein. Additional 
Apolipoprotein-based nanoparticle systems have been developed that may vary in diameter 
with respect to the classical Nanodisc33,36,40. Generally, the size of a nanodisc is dictated by 
the length of the scaffolding Apolipoprotein belt at an optimum lipid content43. The classical 
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Nanodisc technology has been established more than 15 years ago43, but to date the 
application of Nanodiscs for single particle cryo-EM studies has been limited to relatively 
large targets at subnanometer resolution9,10.
In turn, the Salipro nanoparticle technology combines the advantages of adapting to the size 
of the incorporated membrane protein (like detergents or amphipols), while at the same time 
providing a lipid environment. Moreover, the methodology is comparably straightforward to 
adjust for individual membrane proteins. Using the Salipro system, in this study we 
determined a subnanometer resolution structure of a membrane protein without soluble 
domains and embedded in a lipid bilayer environment. The POT complex is a particularly 
challenging target for structural studies by single particle cryo-EM since it contains only 
short loop regions and almost no structural features that stick out of the plane of the 
membrane region. Therefore, image alignment was entirely driven by the structural features 
of the transmembrane domain. This is possibly facilitated by the relatively small dimension 
of the Saposin-lipid scaffold that does not significantly affect the alignment process, while at 
the same time this protein-lipid scaffold surrounding the membrane protein also enhances 
the contrast in cryo-conditions (Fig. 3 & 4, Supplementary Fig. 3).
Previously it had been shown that two Saposin A molecules encapsulate a lipid core16. Here, 
in the presence of a large membrane protein complex, we observe that several Saposin A 
proteins may encircle a larger hydrophobic lipid/protein assembly in the case of the 
homotetrameric POT transporter (Fig. 4a, Supplemental Video 1). This suggests a significant 
flexibility of Saposin A to assemble into homogenous and stable lipoprotein-complexes, by 
adapting to the size of the incorporated molecules. This intrinsic flexibility of Saposin A-
lipid complexes is likely to facilitate the formation of nanoparticles that can accommodate 
membrane protein of different sizes and, at the same time, assists in the formation of 
homogenous lipid nanoparticles (Fig. 2-4).
Moreover, we also present a method to extract and stabilize fragile membrane proteins from 
the virus membrane. The HIV-1 spike is the only viral protein that is exposed to the immune 
system by intact virus particles and therefore an interesting target for HIV vaccine 
development25,44,45. Antigen candidates that could preserve or sufficiently well mimic the 
native conformation of the HIV-1 spike including the important membrane domain have long 
been sought-after44,45. It has been shown that those regions proximal to the membrane as 
well as the membrane domain of the HIV-1 spike are important for the generation of broadly 
neutralizing antibodies against this virus46-48.
To our knowledge, the HIV spike protein preparation presented here using the Salipro 
system represents the first approach that allows the stabilization of the HIV-1 spike, 
including the important membrane domains, in a soluble and functional state. Thus, the 
strategy applied here, may represent a novel approach for the generation of immunogen/
vaccine candidates that might induce broadly neutralizing antibodies (BNAbs) against 
HIV-1. We envisage that this approach is applicable to other viral envelope proteins such as 
Influenza virus HA, Ebola virus G protein or Hepatitis C virus E protein.
Frauenfeld et al. Page 8
Nat Methods. Author manuscript; available in PMC 2016 September 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
In summary, Salipro particles provide a novel versatile nanoparticle platform for membrane 
proteins and may offer a wide range of potential applications, ranging from structural 
biology to the discovery of new pharmacological agents as well as the therapeutic delivery 
of protein-based therapeutics and vaccines.
 Online Methods
 Materials and reagents
All detergents were purchased from Affymetrix. Luria-Bertani, Miller (LB) and Terrific 
broth (TB) from Formedium. Kanamycin was obtained from Duchefa Biochemie and 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) from Saveen Werner. Soluble human CD4 
(4d-CD4) was obtained from Invitrogen. The PG16 and 17b antibody32 were obtained from 
NIH AIDS Research and Reference Reagent Program (ARRRP). We generated Fab 
fragments for ligand binding studies by digesting 18 μg of monoclonal antibody in 25 μl of 
phosphate-buffered saline (PBS) containing 10 mM EDTA, 5 mM Cys, and 0.5 μg of papain 
for 4 h at 37°C. The digestion was terminated by addition of iodoacetamide to 5 mM. 
Samples were diluted with 175 μl of HNC buffer (50 mM HEPES, 100 mM NaCl, 1.8 mM 
CaCl2 [pH 7.4]) and uncleaved antibodies and Fc fragments were removed by binding to 
protein A-Sepharose (GE Healthcare, Uppsala, Sweden) overnight at 4°C. All other 
chemicals were from Sigma-Aldrich, unless otherwise stated.
 Expression and Purification of Saposin A
Protein expression was carried out using a vector with the coding region for Saposin A 
inserted into a pNIC-Bsa4 plasmid. The cloning vector pNIC28-Bsa4 adds an N-terminal 
hexahistidine tag with an integrated TEV protease cleavage site. The cleaved target protein 
represents the Saposin A polypeptide with three additional N-terminal Ser-Met-Gly residues 
as a result of the cloning strategy. The protein was expressed using E. coli Rosetta gami-2 
(DE3) (Novagen). Cells were grown at 37 °C in TB medium supplemented with 
Tetracycline, Chloramphenicol and Kanamycin and induced with 0.7 mM IPTG. Three 
hours after induction the cells were collected by centrifugation at 12.000×g for 15 min and 
the supernatant discarded. The cell pellet was resuspended in lysis buffer (20 mM Hepes pH 
7.5, 150 mM NaCl, 20 mM Imidazol) and disrupted by sonication. Lysates were subjected to 
centrifugation at 26.000×g for 30 min, the supernatant heated to 85 °C for 10 min, followed 
by an additional centrifugation step at 26.000×g for 30 min. Preparative IMAC purification 
was performed by batch-adsorption of the supernatant by end-over-end rotation with Ni 
SepharoseTM 6 Fast Flow medium for 60 min. After binding of Saposin A to the IMAC 
resin, the chromatography medium was packed in a 10-mm-(i.d.) open gravity flow column 
and unbound proteins were removed by washing with 15 bed volumes of lysis buffer. The 
resin was washed with 15 bed volumes of wash buffer WB2 (20 mM Hepes pH 7.5, 150 mM 
NaCl, 40 mM Imidazol). Saposin was eluted by addition of five bed volumes of elution 
buffer EB (20 mM Hepes pH 7.5, 150 mM NaCl, 400 mM Imidazol). The eluate was 
dialyzed overnight against gel filtration buffer GF (20 mM Hepes pH 7.5, 150 mM NaCl) 
supplemented with recombinant TEV protease. TEV protease containing an un-cleavable 
His-tag was removed from the eluate by passing it over 2 ml IMAC resin. Cleaved target 
protein was concentrated to a volume of 5 ml using centrifugal filter units and loaded onto a 
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HiLoad SuperdexTM 200 16/60 GL column using an ÄKTAexplorer 10 chromatography 
system. Peak fractions were pooled and concentrated to 1.2 mg/ml protein. Typically, a 1-
liter bacterial culture yields 5-10 mg of purified Saposin. The protein sample was flash 
frozen in liquid nitrogen and stored at − 80 °C.
 Expression and Purification of POT1 and T2
POT1 was expressed and purified following a described recently18,19. T2 was purified as 
described recently17.
 Generation of Salipro lipid particles
Detergent-solubilized lipids were prepared by dissolving lipid-powder (various lipids from 
Sigma-Aldrich) in buffer D (50 mM Hepes pH 7.5, 150 mM NaCl, 1 % DDM) to obtain a 
stock solution that contained 20 mg/ml lipids and incubated for 1h at 37 °C. If not otherwise 
stated, a brain lipid extract from bovine brain, Type I (Sigma-Aldrich) was used for 
nanoparticle generation. Prior to Salipro particle reconstitution, the lipid stock solutions 
were diluted to 5 mg/ml using buffer E (50 mM Hepes pH 7.5, 150 mM NaCl, 0.03 % 
DDM). For the reconstitution of Salipro particles, 10 μl of purified Saposin A and 5 μl of the 
respective detergent-solubilized lipids were incubated for 10 min at 37 °C. Subsequently, 50 
μl of GF-buffer was added to the mixture and incubated for 10 min at room temperature. The 
reconstitution mixture was subjected to a gel-filtration analysis on Superdex S200 5/150 
analytical gel filtration column (GE Healthcare) and eluted with GF-buffer, giving rise to a 
monodisperse peak of Salipro particles. For a medium scale preparation, 60 μl of a brain-
lipid solution (5 mg/ml brain lipids, Sigma-Aldrich; 50 mM Hepes pH 7.5, 150 mM NaCl, 
0.28% DDM) were incubated with 100 μl of purified Saposin A (1.2 mg/ml, 20 mM Hepes 
pH 7.5, 150 mM NaCl), incubated for 5 min at 37°C and 160 μl gel filtration buffer GF 
added, followed by incubation of the mixture for 10 min at RT. Then, 230 μl of GF-buffer 
were added and the sample was subjected to a gel-filtration step on a Superdex200 10/300 
GL column using an ÄKTAexplorer 10 chromatography system equilibrated with GF-buffer. 
Fractions containing Salipro particles were pooled and concentrated to 1 mg/ml using 
Amicon Centricon filter devices at 3000 × g.
In one experiment, Salipro particles were generated after incubation with an increasing 
excess of lipids. Here, varying amounts ("Lipids 5": 5 μg, "Lipids 12.5": 12.5 μg, "Lipids 
25": 25 μg, "Lipids 50": 50 μg, "Lipids 100": 100 μg) from a brain-lipid solution (5 mg/ml 
brain lipids, Sigma-Aldrich; 50 mM Hepes pH 7.5, 150 mM NaCl, 0.28% DDM) were 
incubated for 10 min at 37 °C. 10 μl of purified Saposin A (1.2 mg/ml, 20 mM Hepes pH 
7.5, 150 mM NaCl) were added, incubated for 1 min at 37 °C and GF-buffer was added to a 
final volume of 41 μl. After 10 min incubation at RT, 24 μl of GF-buffer pH 7.5 were added 
and the samples were subjected to a gel-filtration step on a SuperdexTM 200 5/150 GL 
analytical gel filtration column using a ÄKTAmicroTM chromatography system (both GE 
Healthcare) equipped with the Autosampler A-905, which automatically injected 25 μl of 
protein containing sample. Analytical gel filtration runs were performed at 4 °C at a flow 
rate of 0.2 ml/min in GF-buffer.
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 Incorporation of membrane proteins into Salipro Particles
To reconstitute the archaeal mechanosensitve channel T2 into Salipro nanoparticles, 5 μl of a 
brain-lipid solution (5 mg/ml brain lipids, Sigma-Aldrich; 50 mM Hepes pH 7.5, 150 mM 
NaCl, 0.28% DDM) were incubated for 5 min at 37 °C, 2 μl of purified membrane protein 
T2 (10 mg/ml, 20 mM TrisHCl pH 7.5, 150 mM NaCl, 5 % glycerol, 0.03% DDM) were 
added and subjected to a second incubation step at 37°C. Subsequently, 20 μl of purified 
Saposin A (1.2 mg/ml, 20 mM Hepes pH 7.5, 150 mM NaCl) were added and incubated for 
5 min at 37 °C. Then, 24 μl of 1xPBS pH 7.4 were added and the mixture was incubated for 
5 min at RT, followed by adding 39 μl of 1xPBS pH 7.4 to the mixture. The sample was 
subjected to a gel-filtration step on a Superdex S200 5/150 analytical gel filtration column, 
equilibrated and eluted with 1x PBS pH 7.4.
For a medium scale preparation of Salipro-T2, 40 μl of a brain-lipid solution (5 mg/ml brain 
lipids, Sigma-Aldrich; 50 mM Hepes pH 7.5, 150 mM NaCl, 0.28% DDM) and 5 μl of 
protease inhibitor stock solution (1 cOmplete EDTA-free tablet in 1 ml H2O) were incubated 
for 5 min at 37 °C, 20 μl of purified membrane protein T2 (10 mg/ml, 20 mM TrisHCl pH 
7.5, 150 mM NaCl, 5 % glycerol, 0.03% DDM) were added and subjected to a second 
incubation step at 37°C. Subsequently, 140 μl of purified Saposin A (1.2 mg/ml, 20 mM 
Hepes pH 7.5, 150 mM NaCl) were added and incubated for 5 min at 37 °C. Then, 145 μl of 
1xPBS pH 7.4 were added and incubated for 5 min at RT, followed by adding 150 μl 1x 
PBS. The sample was subjected to a gel-filtration step on a Superdex200 10/300 GL column 
using an ÄKTAexplorer 10 chromatography system equilibrated with 1xPBS pH 7.4. 
Fractions containing Salipro-T2 were pooled and concentrated to 1 mg/ml using Amicon 
Centricon filter devices at 3000 × g. The protein sample was flash frozen in liquid nitrogen 
and stored at − 80 °C.
To reconstitute the bacterial peptide transporter POT1 into Salipro nanoparticles, 5 μl of a 
brain-lipid solution (5 mg/ml brain lipids, Sigma-Aldrich; 50 mM Hepes pH 7.5, 150 mM 
NaCl, 0.28% DDM) were incubated for 5 min at 37 °C, 2 μl of purified membrane protein 
POT1 (10 mg/ml, 20 mM TrisHCl pH 7.5, 150 mM NaCl, 5 % glycerol, 0.4% NM) were 
added and subjected to a second incubation step at 37°C. Subsequently, 15 μl of purified 
Saposin A (1.2 mg/ml, 20 mM Hepes pH 7.5, 150 mM NaCl) were added and incubated for 
5 min at 37 °C. Then, 19 μl of 1xPBS pH 7.4 were added and the mixture was incubated for 
5 min at RT, followed by adding 39 μl of 1xPBS pH 7.4 to the mixture. The sample was 
subjected to a gel-filtration step on a Superdex S200 5/150 analytical gel filtration column, 
equilibrated and eluted with 1x PBS pH 7.4.
For a medium scale preparation of Salipro-POT1, 40 μl of a brain-lipid solution (5 mg/ml 
brain lipids, Sigma-Aldrich; 50 mM Hepes pH 7.5, 150 mM NaCl, 0.28% DDM) were 
incubated for 5 min at 37 °C, 20 μl of purified membrane protein POT1 (10 mg/ml, 20 mM 
TrisHCl pH 7.5, 150 mM NaCl, 5 % glycerol, 0.4% NM) were added and subjected to a 
second incubation step at 37°C. Subsequently, 100 μl of purified Saposin A (1.2 mg/ml, 20 
mM Hepes pH 7.5, 150 mM NaCl) were added and incubated for 5 min at 37 °C. Then, 150 
μl of 1xPBS pH 7.4 were added and incubated for 5 min at RT, followed by adding 220 μl 1x 
PBS. The sample was subjected to a gel-filtration step on a Superdex200 10/300 GL column 
using an ÄKTAexplorer 10 chromatography system equilibrated with 1xPBS pH 7.4, 5% 
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glycerol. Fractions containing Salipro-POT1 were pooled and concentrated to 0.7 mg/ml 
using Amicon Centricon filter devices at 3000 × g. The protein sample was flash frozen in 
liquid nitrogen and stored at − 80 °C.
In one experiment, the effect of pH on POT1 reconstitution into Salipro particles was tested. 
Here, to reconstitute the bacterial peptide transporter POT1 into Salipro nanoparticles, 18 μl 
of a brain-lipid solution (5 mg/ml brain lipids, Sigma-Aldrich; 50 mM Hepes pH 7.5, 150 
mM NaCl, 0.28% DDM) were incubated for 5 min at 37 °C, 5 μl of purified membrane 
protein POT1 (10 mg/ml, 20 mM TrisHCl pH 7.5, 150 mM NaCl, 5 % glycerol, 0.03% 
DDM) were added and subjected to a second incubation step at 37°C. Subsequently, 80 μl of 
purified Saposin A (1.2 mg/ml, 20 mM Hepes pH 7.5, 150 mM NaCl) were added and 
incubated for 5 min at 37 °C. From this mixture, 23 ul were transferred into a single tube 
each and 50 μl of buffers with various pH added (pH 4.5: 20 mM Trisodium citrate, 100 mM 
NaCl; pH 6: 20 mM Trisodium citrate, 100 mM NaCl; pH 7.5: 20 mM TrisHCl, 100 mM 
NaCl; pH 9: 20 mM TrisHCl, 100 mM NaCl). After 5 min incubation, the samples were 
subjected to a gel-filtration step on a Superdex S200 5/150 analytical gel filtration column, 
equilibrated and eluted with buffers at the corresponding pH (4.5-9).
 Negative stain electron microscopy
Salipro lipid-only discs: Carbon coated copper grids (400 mesh) were glow discharged in 
low pressure air to render them hydrophilic for 20 sec before application of 4 μl sample for 
30 sec. Washing was done with three drops of water before staining with 4 μl of uranyl 
formate (1%, Polysciences, USA) for 30 sec. The grids were air dried after removal of 
excess stain solution by torn filter paper. Negative stain image data were collected with a 
JEOL2100F field emission gun transmission electron microscope at an accelerating voltage 
of 200kV and a final magnification of 69500 on a CCD camera (4K × 4K, Tiez Video and 
Image Processing System, GmbH Gauting, Germany) with 15 mm pixel size (corresponding 
to 2.16 Å on the specimen level).
Salipro-T2 samples were stained with uranyl acetate and imaged on an FEI TECNAI Polara 
TEM at 100 kV at a magnification of 59kx and a pixel size of 1.91 A on a UltraScan 4000 
CCD (Gatan, Inc.). Individual particles were windowed semi-automatically with the swarm 
option of e2boxer (EMAN2 package50). After normalization, 33000 particles were subjected 
to reference-free 2D classification and class-averaging using the EMAN2 routines 
(e2refine2d).
 Thermal unfolding analysis
Thermal unfolding analysis was performed using dye-free differential scanning 
fluorimetry20 using two samples each for POT in detergent (1x PBS, pH 7.4, 0.4% NM) and 
Salipro-POT (1x PBS pH 7.4) with a sample volume of 10 μl per capillary at concentrations 
of 0.2 mg/ml. The temperature was increased by 1°C/min from 20°C to 95°C using a 
Prometheus NT.48 instrument (Nanotemper).
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 Cryo-EM
The PepT data was collected and processed as described51. 2.5 μl of purified sample at 0.7 
mg/ml concentration was applied to a glow discharged Quantifoil holey carbon grid (400 
mesh, 1.2 um hole size) and blotted at 100% humidity using FEI Vitrobot Mark I for 5.5 s 
blotting time. Images of the vitrified sample were subsequently collected on FEI TF30 
Polara electron microscope operated at 300 kV, equipped with a Gatan K2 Summit direct 
electron detector camera. The images were recorded with a defocus in a range from 1.5 to 
2.5 mm at a nominal magnification of 31,000, corresponding to a calibrated physical pixel 
size of 1.2156 Å/pixel on the specimen at a dose rate on the camera set to 8.2 counts per 
physical pixel per second. The sample was exposed for a total time of 6s, with each image 
fractionated into 30 subframes, each with an accumulation time of 0.2 s per frame, with the 
total accumulated dose of 41e-/Å2 on the specimen.
 Image processing
Dose-fractionated super-resolution image frames were drift-corrected using whole-frame 
motion correction23; a sum of all subframes in each image stack was used for further 
processing. The particles embedded in vitreous ice were monodisperse and exhibited a good 
contrast (Fig. 3a), even at low defocii.
For all 2D image display and particle picking, SamViewer, an interactive image analysis 
program written in Python was used. Defocus was determined using CTFFIND452. Particle 
extraction and class averaging was performed in RELION53. Using 12200 particles, we 
performed 2D classification (Fig. 3b) and obtained classes with a large number of inner-
membrane details. Selected classes were extracted and probabilistic initial 3D model 
generation procedure (PRIME) implemented in SIMPLE54 package was used for an ab initio 
3D reconstruction generation; This served as a reference model for the maximum likelihood-
based 3D classification and auto-refinement procedure implemented in RELION. For the 
final 3D reconstruction (Fig. 4a,b) 9,913 particles were used and C4 symmetry was imposed; 
resolutions were estimated using the FSC 0.143 criterion24 on corrected FSC curves to 
obtain the map at 6.48 Å (Fig. 3e). ResMap was used to estimate local resolution from 
unbinned and unsharpened raw density map55. Figures were prepared using UCSF 
Chimera56.
 HIV virus like particle production
VLPs carrying HIV-1 JR-FL spikes with a deleted cytoplasmic tail (truncated at residue 
708), disulfide linked gp120 and gp41 (Cys501-Cys605), and E168K and N189A mutations 
(facilitates binding of the PG16 antibody to the JR-FL spike) were produced in 293T cells 
by calcium phosphate precipitation-mediated cotransfection. For production of [35S]Cys 
labelled VLPs one 150 cm2 culture flask semi confluent 293T cells was transfected using 10 
μg of pCAGGS JRFL gp160SOS,△CT,E168K,N189A and 10 μg of pNL4-3.Luc.R-E 
DNA57,58. [35S]Cys was incorporated into the VLPs through metabolic labeling in Cys-free 
Dulbecco′s modified Eagle medium (National Veterinary Institute, Uppsala, Sweden) 
supplemented with 10 μM unlabeled Cys and 100 μCi of [35S]Cys/ml (Fisher Scientific, 
Gothenburg, Sweden) from 24 to 48 h after the transfection. Cell debris was removed from 
the virus-contain media using low speed centrifugation, 1000 rpm for 10 min. The cleared 
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supernatant was layered on top of a step gradient composed of 1 ml of 60% and 4.5 ml of 
20% sucrose (wt/wt) in HN buffer (50 mM HEPES, 100 mM NaCl, pH 7.4,) and centrifuged 
at 4°C for 2 h at 93,000 × g (22,000 rpm) in a Beckman SW28.1 rotor. Radiolabeled virus 
was collected from the 20/60% sucrose interphase. For unlabelled VLP production 15 
culture flasks (150 cm2) with 293T cells were transfected and the virus collected and 
concentrated as above. To increase VLP concentration the virus was diluted to 15-20% 
sucrose in HN buffer and added on top of a 1 ml 60% (wt/wt) sucrose cushion followed by a 
second ultra centrifugation at 4°C for 6 h at 22,000 rpm using the SW28.1 rotor. The virus 
was collected by fractionation from the bottom and fractions were analysed using SDS-
PAGE and Sypro Ruby protein stain to visualize the VLP peak for collection.
 Incorporation of the trimeric HIV-spike into the Salipro nanoparticles
VLPs were lysed for 10 min on ice in HN buffer supplemented with 9 mM HEGA-10 in the 
presence of Saposin A, and in some cases brain lipids. HEGA-10 was then removed by two 
successive spin SEC steps (Zeba Spin Desalting Columns, 7K MWCO). The columns were 
washed and centrifuged according to manufacturer's instructions (Pierce). The column 
removes the HEGA-10 detergent but not saposin A, which with viral lipids replaces the 
detergent in the spike detergent complexes. Salipro-HIV-spike particles eluted from the 
column void volume together with the other soluble virus proteins. The sample was then 
incubated for 15 min at 37°C before lectin purification of the Salipro-HIV-spike particles.
 Purification of the Salipro-HIV-spike particles
Salipro-HIV-spikes were purified using Galanthis Nivalis lectin (Sigma-Aldrich) affinity 
chromatography. The lectin binds to high mannose sugar moieties on the spike protein. The 
column was washed with 50 column volumes HN buffer followed by elution of the Salipro-
HIV-spike particles using 0.3M methyl-αD-mannopyranoside. The methyl-αD-
mannopyranoside was removed from the sample using a spin SEC column (Zeba Spin 
Desalting Columns, 7K MWCO) and changed to HN buffer. The Salipro-HIV-spikes were 
concentrated by ultra filtration using an Amicon Ultra-4 50K MWCO centrifugation filter 
(Millipore) and sample purity was assayed with SDS-PAGE using Sypro Ruby protein 
staining (Lonza group Ltd) and BN-PAGE using silver staining (Thermo Scientific).
 Functional assays of the Salipro-HIV-spikes
Salipro-HIV-spike particles were incubated with 10 μg/ml of PG16 antibody, sCD4 and 17b 
Fab, respectively, in HN buffer for 2 h at 37°C. The formation of ligand spike complexes 
was followed by BN-PAGE and phosphorimaging. One volume of two times-concentrated 
BN-PAGE sample buffer was added, and the samples were incubated for 10 min at room 
temperature and analyzed by gradient BN-PAGE containing 3 to 8% total acrylamide as 
described previously59. The dried gels were exposed to phosphorimage screens (BAS 
MS2025; Fujifilm, Science Imaging, Nacka, Sweden) and the radiolabeled bands visualized 
using a Molecular Imager FX and the Quantity One software (Bio-Rad, Hercules, CA).
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Saposin-lipoprotein nanoparticles for the incorporation of lipids, membrane proteins 
and viral antigens
By incubating Saposin A with lipids and membrane proteins it is possible to generate 
soluble and stable nanoparticles that adjust to the size of the incorporated molecule. Models 
of Saposin-Lipid-complexes were adapted from pdbs: 4ddj, 4aps, 4nco, 3din, 2dob; virus 
envelope structure modified49
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Figure 2. Salipro particles with lipids and the T2 channel
(a) Gel filtration analysis of Saposin A after incubation with the indicated detergent 
solubilised lipid solutions. The void volume is marked with an asterisk, the peaks for 
monomeric Saposin with (^) and Saposin-lipid complexes with (#). (b) Gel filtration 
analysis of the incorporation of the pentameric T2 channel into Salipro nanoparticles. The 
void volume is marked with an asterisk, the peaks for monomeric Saposin with (^), Saposin-
lipid complexes with (#) and Salipro-T2 with (◇). (c) A representative micrograph of T2 in 
Salipro discs stained with uranyl acetate. Individually side and top views of the reconstituted 
channel can be seen. Scale bar is 100 nm. (d) Selected 2D class averages of Salipro-T2, the 
boxsize is 243 Å.
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Figure 3. Single particle cryo-EM of Salipro-POT
(a) Raw micrograph of PepTSO2 bacterial transporter collected using K2 Gatan direct 
electron camera. Scale bar is 50 nm. (b) Representative 2D class averages generated from 
the particles, the boxsize is 235 Å. (c) Gold-standard FSC curves between two 
independently refined half maps. (d) Selected slice views of the unsharpened 3D density 
map. The views are oriented in parallel with the membrane plane. The numbers of slices are 
marked. (e) Euler angle distribution of all particles included in calculating the final 3D 
reconstruction. The size of the ball is proportional to the number of particles in this specific 
orientation. (f) Final 3D reconstruction colored with local resolution, as seen from top 
(right), sliced parallel to the plane of the membrane (middle) and side view cut 
perpendicularly to the plane of the membrane (right).
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Figure 4. Cryo-EM structure of Salipro-POT
(a) 3D density map of the tetrameric bacterial transporter, filtered to 6.5 Å with each of the 
subunits and tentative placement of Saposin (orange and blue, respectively) in the density. 
Top view and side view cut perpendicularly to the plane of the membrane, dimensions are 
indicated. (b) Representative views of the cryo-EM density and rigidly fitted X-ray 
crystallography model (PDBID: 4TPH). The density shows a good fit of the model. The EM 
map reveals loop densities that could not be resolved in the X-ray structure. (c) Selected side 
chains densities of bulky residues such as Arg, Trp, Phe and Tyr.
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Figure 5. Stabilization of soluble and functional HIV-1 spike proteins within Salipro 
nanoparticles
(a) Schematic illustration of the HIV-1 spike protein in the viral membrane. The HIV-1 
Envelope glycoprotein, i.e. the spike, consists of two subunits, the peripheral gp120 subunit 
(brown) and the transmembrane gp41 subunit (grey), forming a heterotrimer. The binding 
site for the CD4 receptor and epitopes for the antibodies PG16 and 17b are shown (yellow). 
(b) Schematic illustration of the Salipro-HIV-spike reconstitution. Purified VLPs containing 
HIV-1 spikes (brown) were mixed with Saposin A (blue) and solubilized with HEGA-10 
followed by detergent removal, leading to the formation of Salipro-HIV-spikes. (c) 
Reconstitution of the HIV-1 spike into Salipro nanoparticles. BN-PAGE analysis reveals that 
the solubility of the HIV-1 spike (3x gp) can be maintained by Saposin A upon detergent 
removal. (d) Lectin purification of Salipro-HIV-spikes. Particle purity was assayed using 
SDS-PAGE and Sypro Ruby protein staining. The gels show efficient removal of 
contaminating viral internal proteins. (e) The HIV-1 spike has a native fold and preserves its 
function in Salipro nanoparticles. The Salipro-HIV-spike particles were incubated at 37°C 
for 16 and 90 h followed by 2 h incubation at 37°C with 10 μg/ml of the HIV-1 spike 
ligands, PG16 antibody (150 kDa) (lane 3), sCD4 (50 kDa) (lane 4), sCD4 and 17b Fab (50 
kDa) together (lane 5), 17b Fab alone (lane 6) or without a ligand (lane 2) and analyzed by 
BN-PAGE. A control sample without any ligand was kept on ice (lane 1). Binding of the 
ligands can be followed by the reduced migration of the Salipro-HIV-spike particles.
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